サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1682037

細胞溶解と分画の世界市場レポート 2025年

Cell Lysis And Fractionation Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
細胞溶解と分画の世界市場レポート 2025年
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細胞溶解と分画市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.0％で48億9,000万米ドルに成長します。予測期間の成長は、個別化医療への注目の高まり、研究に対する政府資金の増加、効果的な手法に対する高い需要、ゲノミクスとプロテオミクスの分野における技術進歩、慢性疾患と感染症の有病率の上昇などに起因しています。予測期間における主な動向としては、個別化医療アプローチの採用の継続的成長、溶解・分画プロセスにおける自動化・ロボット化の進展、臨床診断および医薬品開発におけるアプリケーションの拡大、細胞分析用マイクロ流体およびラボオンチップ技術の進歩、ポイントオブケアおよび分散型検査ソリューションの重視の高まりなどが挙げられます。

個別化医療への注目の高まりが、今後の細胞溶解と分画市場の成長を促進すると予想されます。個別化医療とは、個人の遺伝子プロファイルを病気の診断や治療に利用する新たな医療行為です。この医療では、医療上の決定や治療を患者一人ひとりの特性に合わせて調整する必要があり、特に遺伝子構成に重点を置いています。細胞溶解と分画は、タンパク質、細胞小器官、核酸など、患者のサンプルから特定の細胞内要素を分離・分析することを可能にすることで、精密医療において重要な役割を果たしています。これにより、科学者や医療専門家は、病気の根底にある分子プロセスを調査し、各患者のユニークな分子特性に応じてカスタマイズされた治療を作成することが可能になります。例えば、個別化医療の理解と普及を推進する米国の団体、個別化医療連合（PMC）によると、2022年10月には、複数の種類のがん、遺伝性希少疾患、さまざまな慢性疾患や感染症の患者を対象に、75,000以上の遺伝子検査製品と300以上の個別化医薬品が市場に出回ることになります。したがって、個別化医療への注目の高まりが細胞溶解と分画市場の成長を牽引しています。

細胞溶解と分画市場で事業を展開する主要企業は、市場での競争力を高めるため、CGT（細胞・遺伝子治療）ウイルスベクター溶解キットなどの先進ソリューションの導入に注力しています。これらの溶解キットは、簡素化されたAAV（アデノ随伴ウイルス）溶解手法を提供し、バイオプロセシングのワークフローを標準化しながら、SOP（標準操作手順）、品質管理、安全性を向上させる。例えば、2023年7月、ドイツを拠点とするサンプルおよびアッセイ技術のプロバイダーであるQIAGEN社は、新しいCGTウイルスベクター溶解キットを発売しました。このキットは、細胞溶解液から始める正確で均一な手順で、いくつかの血清型のウイルス力価を定量することを可能にします。新しいCGTウイルスベクター溶解キットは、バイオ医薬品業界向けに急速に拡大しているQIAGENのデジタルPCRポートフォリオを補完するもので、すでに宿主細胞DNAのキャリーオーバーをチェックする3種類のQIAcuity Residual DNA Quantification Kitや、アデノ随伴ウイルス（AAV）力価定量に使用する10種類のQIAcuity Cell and Gene Therapy（CGT）dPCR Assaysがあります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界細胞溶解と分画PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の細胞溶解と分画市場：成長率分析
  • 世界の細胞溶解と分画市場の実績：規模と成長, 2019-2024
  • 世界の細胞溶解と分画市場の予測：規模と成長, 2024-2029, 2034F
  • 世界細胞溶解と分画総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の細胞溶解と分画市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 哺乳類細胞
  • 微生物細胞
  • 世界の細胞溶解と分画市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 核酸の精製と分離
  • タンパク質の精製と分離
  • 世界の細胞溶解と分画市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 調査室および研究所
  • バイオ医薬品
  • バイオテクノロジー企業
  • 世界の細胞溶解と分画市場、哺乳類細胞のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 接着性哺乳類細胞
  • 懸濁哺乳類細胞
  • 一次細胞
  • 細胞株
  • 世界の細胞溶解と分画市場微生物細胞のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 細菌細胞
  • 酵母細胞
  • 真菌細胞
  • 藻類細胞

第7章 地域別・国別分析

  • 世界の細胞溶解と分画市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の細胞溶解と分画市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 細胞溶解と分画市場：競合情勢
  • 細胞溶解と分画市場：企業プロファイル
    • Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Lonza Group AG
  • Illumina Inc.
  • Beckman Coulter Inc.
  • PerkinElmer Inc.
  • IDEX Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Eppendorf AG
  • Miltenyi Biotec B.V. & Co. KG
  • Promega Corporation
  • Takara Bio Inc.
  • Abcam plc
  • Cell Signaling Technology Inc.
  • BioVision Inc.
  • Diagenode LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 細胞溶解と分画市場2029：新たな機会を提供する国
  • 細胞溶解と分画市場2029：新たな機会を提供するセグメント
  • 細胞溶解と分画市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r27643

Cell lysis is the process of breaking open a cell, which allows the release of its contents, while cell fractionation is a multi-step laboratory procedure used to divide a cell's organelles into various layers or fractions or sections.

The main types of cell lysis and fractionation are mammalian cells and microbial cells. Mammalian cells are eukaryotic cells that are derived from mammals and are used in cell culture and biomanufacturing of therapeutic proteins and viral vaccines. These are used for various applications, such as nucleic acid purification and isolation and protein purification and isolation, and are used by several end users, including research laboratories and institutes, biopharmaceutical, and biotechnology companies.

The main types of cell lysis and fractionation are mammalian cells and microbial cells. Mammalian cells are eukaryotic cells that are derived from mammals and are used in cell culture and biomanufacturing of therapeutic proteins and viral vaccines. These are used for various applications, such as nucleic acid purification and isolation and protein purification and isolation, and are used by several end users, including research laboratories and institutes, biopharmaceutical, and biotechnology companies.

The cell lysis and fractionation market size has grown strongly in recent years. It will grow from $3.42 billion in 2024 to $3.72 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing investments in life science research, growing focus on personalized medicine, high prevalence of diseases, technological advancements in cell lysis and fractionation methods, rising demand for biopharmaceuticals and biotechnology products.

The cell lysis and fractionation market size is expected to see strong growth in the next few years. It will grow to $4.89 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growing focus on personalized medicine, increasing government funding for research, high demand for effective cell lysis and fractionation methods, technological advancements in the field of genomics and proteomics, rising prevalence of chronic and infectious diseases. Major trends in the forecast period include continued growth in the adoption of personalized medicine approaches, increasing integration of automation and robotics in lysis and fractionation processes, expansion of applications in clinical diagnostics and drug development, advancements in microfluidics and lab-on-a-chip technologies for cell analysis, growing emphasis on point-of-care and decentralized testing solutions.

A growing focus on personalized medicine is expected to propel the growth of the cell lysis and fractionation markets going forward. Personalized medicine is an emerging practice of medicine that uses an individual's genetic profile for the diagnosis and treatment of disease. It involves tailoring medical decisions and treatments to the individual characteristics of each patient, particularly focusing on their genetic makeup. Cell lysis and fractionation play a crucial part in precision medicine by making it possible to separate and analyze particular subcellular elements from patient samples, including proteins, organelles, and nucleic acids. This makes it possible for scientists and medical professionals to investigate the molecular processes that underlie illness and create customized treatments depending on the unique molecular traits of each patient. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes understanding and adoption of personalized medicine, more than 75,000 genetic testing products and 300 personalized medicines will be on the market for people with multiple types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. Therefore, the growing focus on personalized medicine is driving the growth of the cell lysis and fractionation markets.

Major companies operating in the cell lysis and fractionation market are focused on introducing advanced solutions, such as CGT (cell and gene therapy) viral vector lysis kits, to gain a competitive edge in the market. These lysis kits offer a simplified AAV (Adeno-associated virus) lysis methodology that will improve SOPs (Standard Operating Procedures), quality control, and safety while standardizing bioprocessing workflows. For instance, in July 2023, QIAGEN, a Germany-based provider of sample and assay technologies, launched the new CGT Viral Vector Lysis Kit, which makes it possible to quantify virus titers for several serotypes with an exact and uniform procedure starting with cell lysates. The new CGT viral vector lysis kit complements QIAGEN's rapidly expanding digital PCR portfolio for the biopharma industry, which already includes three QIAcuity Residual DNA Quantification Kits to check for host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays for use in adeno-associated virus (AAV) titer quantification.

In December 2022, MilliporeSigma, a US-based pharmaceutical company, acquired Erbi Biosystems Inc. for an undisclosed amount. With this acquisition, MilliporeSigma aims to strengthen its portfolio and expertise in the field of bioreactors and cell culture technologies. Erbi Biosystems is the developer of the 2 ml micro-bioreactor platform technology known as Breez, which is a micro-scale, fully automated, functionally closed system. Erbi Biosystems Inc. is a US-based biotechnology company that offers microfluidic solutions to enable efficient and controlled cell lysis and fractionation.

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

North America was the largest region in the cell lysis and fractionation market in 2024. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell lysis and fractionation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell lysis and fractionation market consists of revenues earned by entities by providing cellular contents extraction, cytoplasmic separation, and cell disruption. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell lysis and fractionation market also includes sales of cell lysis instruments, cell lysis reagents, and consumables. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Lysis And Fractionation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell lysis and fractionation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell lysis and fractionation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell lysis and fractionation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Mammalian Cells; Microbial Cells
  • 2) By Application: Nucleic Acid Purification And Isolation; Protein Purification And Isolation
  • 3) By End-User: Research Laboratories And Institutes; Biopharmaceutical; Biotechnology Companies
  • Subsegments:
  • 1) By Mammalian Cells: Adherent Mammalian Cells; Suspension Mammalian Cells; Primary Cells; Cell Lines
  • 2) By Microbial Cells: Bacterial Cells; Yeast Cells; Fungal Cells; Algal Cells
  • Companies Mentioned: Hoffmann-La Roche Ltd; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Lysis And Fractionation Market Characteristics

3. Cell Lysis And Fractionation Market Trends And Strategies

4. Cell Lysis And Fractionation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell Lysis And Fractionation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cell Lysis And Fractionation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cell Lysis And Fractionation Market Growth Rate Analysis
  • 5.4. Global Cell Lysis And Fractionation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cell Lysis And Fractionation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cell Lysis And Fractionation Total Addressable Market (TAM)

6. Cell Lysis And Fractionation Market Segmentation

  • 6.1. Global Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammalian Cells
  • Microbial Cells
  • 6.2. Global Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nucleic Acid Purification And Isolation
  • Protein Purification And Isolation
  • 6.3. Global Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Laboratories And Institutes
  • Biopharmaceutical
  • Biotechnology Companies
  • 6.4. Global Cell Lysis And Fractionation Market, Sub-Segmentation Of Mammalian Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adherent Mammalian Cells
  • Suspension Mammalian Cells
  • Primary Cells
  • Cell Lines
  • 6.5. Global Cell Lysis And Fractionation Market, Sub-Segmentation Of Microbial Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Cells
  • Yeast Cells
  • Fungal Cells
  • Algal Cells

7. Cell Lysis And Fractionation Market Regional And Country Analysis

  • 7.1. Global Cell Lysis And Fractionation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cell Lysis And Fractionation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Lysis And Fractionation Market

  • 8.1. Asia-Pacific Cell Lysis And Fractionation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Lysis And Fractionation Market

  • 9.1. China Cell Lysis And Fractionation Market Overview
  • 9.2. China Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Lysis And Fractionation Market

  • 10.1. India Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Lysis And Fractionation Market

  • 11.1. Japan Cell Lysis And Fractionation Market Overview
  • 11.2. Japan Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Lysis And Fractionation Market

  • 12.1. Australia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Lysis And Fractionation Market

  • 13.1. Indonesia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Lysis And Fractionation Market

  • 14.1. South Korea Cell Lysis And Fractionation Market Overview
  • 14.2. South Korea Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Lysis And Fractionation Market

  • 15.1. Western Europe Cell Lysis And Fractionation Market Overview
  • 15.2. Western Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Lysis And Fractionation Market

  • 16.1. UK Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Lysis And Fractionation Market

  • 17.1. Germany Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Lysis And Fractionation Market

  • 18.1. France Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Lysis And Fractionation Market

  • 19.1. Italy Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Lysis And Fractionation Market

  • 20.1. Spain Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Lysis And Fractionation Market

  • 21.1. Eastern Europe Cell Lysis And Fractionation Market Overview
  • 21.2. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Lysis And Fractionation Market

  • 22.1. Russia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Lysis And Fractionation Market

  • 23.1. North America Cell Lysis And Fractionation Market Overview
  • 23.2. North America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Lysis And Fractionation Market

  • 24.1. USA Cell Lysis And Fractionation Market Overview
  • 24.2. USA Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Lysis And Fractionation Market

  • 25.1. Canada Cell Lysis And Fractionation Market Overview
  • 25.2. Canada Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Lysis And Fractionation Market

  • 26.1. South America Cell Lysis And Fractionation Market Overview
  • 26.2. South America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Lysis And Fractionation Market

  • 27.1. Brazil Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Lysis And Fractionation Market

  • 28.1. Middle East Cell Lysis And Fractionation Market Overview
  • 28.2. Middle East Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Lysis And Fractionation Market

  • 29.1. Africa Cell Lysis And Fractionation Market Overview
  • 29.2. Africa Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Lysis And Fractionation Market Competitive Landscape And Company Profiles

  • 30.1. Cell Lysis And Fractionation Market Competitive Landscape
  • 30.2. Cell Lysis And Fractionation Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Cell Lysis And Fractionation Market Other Major And Innovative Companies

  • 31.1. Lonza Group AG
  • 31.2. Illumina Inc.
  • 31.3. Beckman Coulter Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. IDEX Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. QIAGEN NV
  • 31.8. Eppendorf AG
  • 31.9. Miltenyi Biotec B.V. & Co. KG
  • 31.10. Promega Corporation
  • 31.11. Takara Bio Inc.
  • 31.12. Abcam plc
  • 31.13. Cell Signaling Technology Inc.
  • 31.14. BioVision Inc.
  • 31.15. Diagenode LLC

32. Global Cell Lysis And Fractionation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Lysis And Fractionation Market

34. Recent Developments In The Cell Lysis And Fractionation Market

35. Cell Lysis And Fractionation Market High Potential Countries, Segments and Strategies

  • 35.1 Cell Lysis And Fractionation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cell Lysis And Fractionation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cell Lysis And Fractionation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer